Cargando…

A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies

Detalles Bibliográficos
Autor principal:	Tikhonova, Maria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940682/ https://www.ncbi.nlm.nih.gov/pubmed/31901571 http://dx.doi.org/10.1016/j.ebiom.2019.11.036

Ejemplares similares

Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration
por: SN, Suresh, et al.
Publicado: (2019)

Chaperonin‐containing TCP‐1 subunit 2‐mediated aggrephagy: A potential target for treating neurodegeneration
por: Chen, Xueshen, et al.
Publicado: (2022)

Targeting Aggrephagy for the Treatment of Alzheimer’s Disease
por: Malampati, Sandeep, et al.
Publicado: (2020)

Protein Aggregates and Aggrephagy in Myopathies
por: Gibertini, Sara, et al.
Publicado: (2023)

Aggrephagy Deficiency in the Placenta: A New Pathogenesis of Preeclampsia
por: Nakashima, Akitoshi, et al.
Publicado: (2021)

Aggrephagy: Selective Disposal of Protein Aggregates by Macroautophagy
por: Lamark, Trond, et al.
Publicado: (2012)

Microbiome insights open new avenues to treat HPV
por: McDermott, Amy
Publicado: (2023)

A new avenue for treatment of chronic hand eczema
por: Schuttelaar, Marie L.A.
Publicado: (2022)

Probing aggrephagy using chemically-induced protein aggregates
por: Janssen, Anne F. J., et al.
Publicado: (2018)

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis
por: Zhang, Yi, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
por: Wang, Youcui, et al.
Publicado: (2021)

Viewing the Brain Through Retina: A New Avenue for Early Diagnosis of Alzheimer’s Disease
por: Zuhair, Varisha, et al.
Publicado: (2023)

Clinico-pathological correlation: Teaching aspects, avenues, and advances
por: JAIN, SUNIL
Publicado: (2022)

Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease
por: Standaert, David G., et al.
Publicado: (2022)

New avenues of sepsis research: obtaining perspective by analyzing and comparing SSCG 2021 and J-SSCG 2020
por: Yatabe, Tomoaki, et al.
Publicado: (2022)

A biochemical reconstitution approach to identify autophagy receptors for aggrephagy in mammalian cells
por: Ma, Xinyu, et al.
Publicado: (2022)

Nanobodies: new avenue to treat kidney disease
por: Wanner, Nicola, et al.
Publicado: (2021)

Inflammation in Health and Disease: New Insights and Therapeutic Avenues
por: Scotece, Morena, et al.
Publicado: (2022)

Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases
por: Li, Qian, et al.
Publicado: (2022)

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
por: Subramaniam, Sudhakar R., et al.
Publicado: (2017)

TECPR1 promotes aggrephagy by direct recruitment of LC3C autophagosomes to lysosomes
por: Wetzel, Lisa, et al.
Publicado: (2020)

UXT chaperone prevents proteotoxicity by acting as an autophagy adaptor for p62-dependent aggrephagy
por: Yoon, Min Ji, et al.
Publicado: (2021)

A chemical genomics-aggrephagy integrated method studying functional analysis of autophagy inducers
por: Kataura, Tetsushi, et al.
Publicado: (2020)

Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity
por: Rajabally, Yusuf A.
Publicado: (2016)

Feeding, mating and animal wellbeing: new insights from phylogenetic comparative methods
por: Mellor, Emma L., et al.
Publicado: (2023)

New Targets and New Technologies in the Treatment of Parkinson’s Disease: A Narrative Review
por: Montemurro, Nicola, et al.
Publicado: (2022)

p62 and NBR1 functions are dispensable for aggrephagy in mouse ESCs and ESC-derived neurons
por: Trapannone, Riccardo, et al.
Publicado: (2023)

Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia
por: Giorgi, Filippo Sean, et al.
Publicado: (2020)

Dexmedetomidine: New avenues
por: Grewal, Anju
Publicado: (2011)

IL-6 Signaling in Monocytes: A Potential Therapeutic Avenue for Stress-Induced Mood Impairments
por: Niraula, Anzela, et al.
Publicado: (2019)

Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
por: Kinet, Rémi, et al.
Publicado: (2023)

Virtual Social Networking Hours: A Vital Personal and Professional Avenue for Connecting Pharmacy Leadership Educators
por: Zumach, Gregory M., et al.
Publicado: (2022)

The BEACH-containing protein WDR81 coordinates p62 and LC3C to promote aggrephagy
por: Liu, Xuezhao, et al.
Publicado: (2017)

TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins
por: Lyu, Lin, et al.
Publicado: (2021)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Do we still need animals? Surveying the role of animal‐free models in Alzheimer’s and Parkinson’s disease research
por: Aerts, Liesbeth, et al.
Publicado: (2022)

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021)

Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
por: Radtke, Franziska A., et al.
Publicado: (2017)

New Avenues in Pharmaceutical Education
por: Udupa, N.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t8ft83g1abg7tlpv3fdivh1ikn